2149 — BaTeLab Co Income Statement
0.000.00%
- HK$2.87bn
- HK$2.54bn
- CNY578.81m
- 36
- 26
- 100
- 56
Annual income statement for BaTeLab Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 88.7 | 213 | 353 | 464 | 579 |
Cost of Revenue | |||||
Gross Profit | 48.7 | 120 | 199 | 257 | 307 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 70.7 | 152 | 254 | 350 | 405 |
Operating Profit | 18 | 60.8 | 98.5 | 113 | 174 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 14 | 57 | 96.8 | 109 | 166 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14 | 57 | 95.3 | 109 | 167 |
Net Income Before Extraordinary Items | |||||
Net Income | 14 | 57 | 95.3 | 109 | 167 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14 | 57 | 95.3 | 109 | 167 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.23 | 0.95 | 1.59 | 1.84 | 2.78 |